Jose Polanco
Gerontology · Union, NJNPI 1043854961
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,756, 3.6 times the $484 reported in 2021. Among gerontology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 224 payments — averaging $24.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$816
- Madrigal Pharmaceuticals$667
- AbbVie$476
- Novo Nordisk$432
- Lilly USA, LLC$389
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,507100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $1,115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 47 | $816 |
| Madrigal Pharmaceuticals | 9 | $667 |
| AbbVie | 12 | $476 |
| Novo Nordisk | 26 | $432 |
| Lilly USA, LLC | 28 | $389 |
| Dexcom, Inc. | 20 | $361 |
| Corcept Therapeutics | 17 | $311 |
| Ardelyx, Inc. | 9 | $164 |
| Abbott | 7 | $115 |
| Exact Sciences | 4 | $111 |
| Boehringer Ingelheim | 4 | $60 |
| Pfizer | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Daiichi Sankyo Inc. | 3 | $43 |
| Medtronic | 1 | $42 |
| Otsuka America Pharmaceutical, Inc. | 1 | $37 |
| GSK | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Jazz Pharmaceuticals Inc. | 2 | $29 |
| Amgen(2 entities) | 2 | $27 |
| Globus Medical | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Mannkind Corporation | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Bausch Health US, LLC | 1 | $14 |
| Intuity Medical Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,507 in reported general payments places this provider in the 95th percentile of 374 gerontology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 35 | $71,328 |
| LinzessLinaclotide | 62 | $50,724 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 12 | $50,209 |
| FarxigaDapagliflozin Propanediol | 36 | $44,915 |
| EliquisApixaban | 42 | $42,242 |
| TrulicityDulaglutide | 19 | $32,593 |
| JardianceEmpagliflozin | 23 | $31,876 |
| XifaxanRifaximin | 13 | $30,717 |
| OzempicSemaglutide | 21 | $30,716 |
| ProliaDenosumab | 12 | $21,056 |
| MounjaroTirzepatide | 14 | $16,828 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 17 | $12,331 |
| XareltoRivaroxaban | 16 | $7,885 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $7,111 |
| Diclofenac Sodium | 47 | $5,265 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $432 | $102,04456 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,115 | $52,02647 claims |
| AbbVieLinzess | $476 | $50,72462 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $389 | $49,42233 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $60 | $44,20740 claims |
| PfizerEliquis | $50 | $42,24242 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $816 | $30,71713 claims |
| AmgenProlia | $27 | $21,05612 claims |
| Johnson & JohnsonXarelto | $15 | $7,88516 claims |
| GSKIncruse Ellipta | $35 | $4,12911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 374 gerontology providers in New Jersey.
Other gerontology in Union
- Dana JonesTeaneck$150K
- Jennifer FoxFlemington$76K
- Susan HermidaBrick$33K
- Jihane SaadeNorth Bergen$9K
- Joseph RudolphCamden$8K
- Jennifer LernerNew Brunswick$7K
- Josephine MachadoNew Brunswick$7K
- Remya JamesNew Brunswick$7K
- Anna HaEnglewood$7K
- Myoung ParkBayonne$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.